Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 30 at 2:00 PM EDT

Register Free →

Request for Information (RFI) on Identifying Basic Research Challenges to Accelerate United States Biotechnology Leadership

Active
892431-26-RFI-0003Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Department of Energy Office of Science, under the Biological and Environmental Research program, issued Request for Information 892431-26-RFI-0003 on September 24, 2026. This RFI is intended for market research to identify critical basic research challenges and scientific bottlenecks necessary to transition from descriptive biology to predictive biosystems design. The initiative focuses on three primary science objectives: translating genetic code into biochemical functions, designing cells and metabolic pathways to control cellular operations, and developing multi-scale computational models to predict the performance of plants and microorganisms. The ultimate goal is to accelerate the production of bio-advantaged materials, chemicals, and fuels to strengthen United States biotechnology leadership. Interested stakeholders are requested to provide succinct responses not exceeding two pages in a machine-readable PDF format by October 15, 2026. Submissions should address near-term scientific bottlenecks occurring within three to five years, missing capabilities for scaling biosystems design, high-priority industrial application areas, and effective models for public-private partnerships. Responses must include the organization name and a point of contact and should be submitted to the DOE Biotech Input email with the specified subject line. This RFI is for planning purposes and does not constitute a solicitation or a promise to issue a contract; furthermore, the DOE will maintain unlimited rights to all submitted information, and no proprietary or classified data should be included.

General Info

DOE RFI for research on predictive biosystems design for bio-advantaged materials and fuels.

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Germantown, MD, USA

Set-Aside

NONE

Documents

(1)

892431-26-RFI-0003: Identifying Basic Research Challenges to Accelerate U.S. Biotechnology Leadership

PDF•rfi

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Energy
Contacts1 person available
OfficeRichland, WA, USA
Organization / AgencyDepartment Of Energy
Office AddressRichland, WA, USA
Contacts
DOE Biotech Input

Full Description

Show more

DOE seeks input on critical basic research challenges, bottlenecks, and missing capabilities needed to transition from descriptive biology to predictive biosystems design. This RFI solicits perspectives on advancing foundational science across biomolecules, cells, microbiomes, and plants to accelerate the production of bio-advantaged fuels, chemicals, and materials. Feedback is specifically requested on fundamental biodesign goals, high-priority biotechnology application areas, and effective collaboration models to help guide BER's strategic priorities, workshop planning, and future funding mechanisms.

Similar Contracts

Same NAICS industry code

NAICS: 541714
New
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Innovative Solutions Opening (ISO)
Solicitation # ARPA-H-SOL-26-162
The Advanced Research Projects Agency for Health (ARPA-H) has issued Innovative Solutions Opening (ISO) ARPA-H-SOL-26-162 for the UNifying Imaging with QUantum Entanglement (UNIQUE) Program. This merit-based solicitation seeks to develop new biomedical imaging capabilities by exploring quantum-derived observables, such as photon correlation signatures and positronium-sensitive interactions, to reveal biological information invisible to current imaging technologies. The agency anticipates awarding multiple Other Transaction (OT) Agreements to proposers who can demonstrate highly innovative and feasible technical approaches. The submission process is divided into two stages, with solution summaries due October 30, 2026, and full proposals due by December 15, 2026. Full proposals must be submitted via the ARPA-H Solutions portal in three volumes: Technical and Management, Cost, and Administrative and Policy Requirements. Evaluation is based on technical innovation and feasibility, proposer capabilities, relevance to the ARPA-H mission, and cost. For-profit organizations that are not small businesses under NAICS 541714 are required to provide a meaningful cost share. Strict compliance is required regarding research security, including disclosures of foreign influence and prohibitions on participation in Malign Foreign Talent Recruitment Programs. Additionally, the program excludes proposals that offer only incremental improvements or utilize human embryos or fetal tissue. Awardees will be expected to provide monthly status reports and participate in semi-annual in-person review meetings, with all key personnel expected to be onboard within 60 days of the award.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

1 day ago

DEADLINE

in 3 months
View Details
NAICS: 541714
New
Federal
HUBBLE DRAFT Program Announcement (PA)
Solicitation # DARPA-PA-26-10_DRAFT
The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office is issuing a presolicitation notice for the HUBBLE program, which aims to develop an in-silico capability for mapping all protein-protein interactions. The goal is to create a comprehensive human interactome hypercatalog, demonstrating its utility by identifying novel diagnostic and therapeutic targets for conditions such as traumatic brain injury. The program is structured in two phases, with Phase 1 lasting 12 months and Phase 2 lasting 18 months. Key deliverables include the development of PPI fingerprinting capabilities, the capture of a minimal interactome for mild traumatic brain injury, and the generation of a massive PPI hypercatalog benchmarked against DARPA-provided experimental datasets. Awards will be issued as Other Transactions for Research under 10 U.S.C. 4021, meaning they are not subject to the Federal Acquisition Regulation or the Defense Federal Acquisition Regulations Supplement. Eligible applicants include large and small businesses, universities, research institutions, and nontraditional defense contractors. Proposers must be registered in the System for Award Management and maintain CMMC Level 1 compliance. Evaluation is based on technical comprehension, technical ability, and the reasonableness of the cost rough order of magnitude. Submissions must be made via DARPA's Broad Agency Announcement Tool, and all abstracts must remain unclassified.
Defense Advanced Research Projects Agcy

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 541714
New
Federal
UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Solicitation # ARPA-H-SN-26-162
The Advanced Research Projects Agency for Health (ARPA-H), through its Health Science Futures Office, has issued Special Notice ARPA-H-SN-26-162 to announce the UNifying Imaging with QUantum Entanglement (UNIQUE) program. This initiative aims to establish a new biomedical imaging paradigm by utilizing quantum-derived observables, specifically entangled or quantum-correlated 511 keV photon pairs, to reveal disease biology that is currently invisible to existing technologies. The program is divided into two primary technical areas: the Imaging Core, which focuses on the physical systems and detectors required to generate and measure quantum-derived imaging contrast, and Quantum AI Interpretation and Fusion, which focuses on developing AI-driven reconstruction methods to integrate these observables into multidimensional imaging representations. This special notice serves as an informational alert and does not constitute a formal solicitation. It announces a hybrid Proposers Day scheduled for October 15, 2026, to prepare the scientific community for an upcoming Innovative Solutions Opening (ISO) expected by September 18, 2026. Interested parties are encouraged to submit a single capability slide via the UNIQUE Teaming Profile Form by September 22, 2026, to participate in lightning talks during the event. Technical inquiries are directed to Program Manager Wilfred Ngwa at UNIQUE@arpa-h.gov.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

1 day ago

DEADLINE

in 19 days
View Details
NAICS: 541714
New
Grant
Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)
Solicitation # RFA-OD-27-009
The National Institutes of Health Office of the Director is offering a limited competition funding opportunity under solicitation RFA-OD-27-009 to renew the Research Evaluation and Commercialization Hub (REACH) program. This initiative aims to accelerate the translation of academic biomedical discoveries into tangible products that enhance public health and patient care by funding the creation of academic entrepreneurship Hubs. These Hubs will provide innovators with essential seed investment, mentorship in product development, and resources for proof-of-concept work to advance high priority technologies aligned with the NIH mission. Selected Hubs will operate as a consortium to establish infrastructure for identifying promising technologies and provide funding for product definition studies, such as prototype development and feasibility research. They will also offer expertise in regulatory, business, legal, and project management areas while fostering skills in entrepreneurship. Success in this program relies heavily on the establishment of public-private partnerships and the acquisition of non-federal funding. Eligible organizations must submit their applications by November 11, 2026, and will undergo a standard peer-review process to determine merit for funding.
National Institutes Of Health Office Of The Director

POSTED

1 day ago

DEADLINE

in about 2 months
View Details
NAICS: 541714
New
Federal
ARPA-H Comprehensive Organ System Modeling in Outer Space (COSMOS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-165
The Advanced Research Projects Agency for Health (ARPA-H) is seeking proposals under solicitation ARPA-H-SOL-26-165 for the Comprehensive Organ System Modeling in Outer Space (COSMOS) initiative. This program aims to determine if microgravity in Low Earth Orbit (LEO) accelerates tissue aging across brain, cardiac, uterine, and kidney tissues compared to terrestrial rates. If the Tissue Aging Rate in Space (TARIS) is found to significantly exceed the Tissue Aging Rate on Earth (TAROE), the initiative intends to establish a high-throughput, autonomous drug screening platform in LEO to make biomedical research and development more cost-effective and faster than Earth-based methods. The project is structured into two sequential phases: a 27-month Phase I focused on establishing and validating microphysiological systems (MPS) to quantify aging rates, and a 15-month Phase II dedicated to developing age-related pathology models for pro-regenerative drug testing. Key requirements include the use of MPS or organoids for at least 75 percent of experimental samples, the creation of LEO twin experiments, and the establishment of a contractual partnership with at least one Fortune 100 biopharmaceutical company. The program schedule spans FY27 through FY30 and includes two planned space launches in months 39 and 41. Awards will be granted via multiple Other Transaction (OT) Agreements to the most advantageous proposers, including universities, non-profits, and businesses. Evaluation is based primarily on the innovation and feasibility of the technical approach, the potential to transform biomedicine, and the team's expertise in managing costs and schedules. Proposers must adhere to strict administrative requirements, including the BIOSECURE Act, NIH Genomic Data Sharing policies, and specific research security and cybersecurity disclosures. Full proposals are due by October 7, 2026.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

2 days ago

DEADLINE

in 12 days
View Details

More opportunities from Department Of Energy

Same awarding agency

NAICS: 332999
LAW MELTER DISCHARGE CHAMBER THERMOCOUPLES AND THERMOWELLS
Solicitation # 387862
Solicitation 387862 is a Request for Proposal issued by Hanford Tank Waste Operations & Closure, LLC (H2C) for a Firm Fixed Price subcontract to provide LAW Melter Discharge Chamber thermocouples and thermowells assemblies. The scope of work encompasses the procurement of materials, fabrication, assembly, cleaning, testing, calibration, packaging, and transport of these assemblies to the Hanford Site. The project is divided into four primary tasks: thermowell assembly, thermocouple probe fabrication, thermocouple assembly, and final packaging and delivery. Award will be granted to the offeror submitting the lowest price technically acceptable proposal, based on an evaluation of technical capabilities, qualifications, and pricing. The procurement process includes rigorous quality and compliance standards, requiring subcontractors to maintain a Quality Assurance program consistent with site form A-6006-661 and utilize calibration standards traceable to the National Institute of Standards and Technology. Deliverables include the hardware and comprehensive Material Test Reports. Proposals must be submitted in two separate volumes: a Technical Proposal detailing the approach, resources, and key personnel, and a Business and Price Proposal including cost breakdowns and conflict of interest disclosures. Following several amendments to update technical specifications and key dates, the final proposal deadline was set for October 8, 2026, with an estimated award date of October 29, 2026, and an expected delivery date of October 28, 2027.
All Other Miscellaneous Fabricated Metal Product Manufacturing

POSTED

3 months ago

DEADLINE

in 13 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS